We also analyzed the relationship between the expression levels of RUNX2/RUNX3 and the infiltration of immune cells in BRCA-basal, BRCA-HER2, and BRCA-luminal breast cancer subtypes (Supplementary Figures 7, 8). Here, RUNX3 is linked to breast carcinoma.